rs398124510
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 2P and 16B. PM4BP6_Very_StrongBS1BS2
The NM_139058.3(ARX):βc.441_464delβ(p.Ala148_Ala155del) variant causes a inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000533 in 813,782 control chromosomes in the GnomAD database, including 2 homozygotes. There are 124 hemizygotes in GnomAD. Variant has been reported in ClinVar as Likely benign (β β ).
Frequency
Genomes: π 0.00071 ( 0 hom., 25 hem., cov: 21)
Exomes π: 0.00051 ( 2 hom. 99 hem. )
Consequence
ARX
NM_139058.3 inframe_deletion
NM_139058.3 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 3.30
Genes affected
ARX (HGNC:18060): (aristaless related homeobox) This gene is a homeobox-containing gene expressed during development. The expressed protein contains two conserved domains, a C-peptide (or aristaless domain) and the prd-like class homeobox domain. It is a member of the group-II aristaless-related protein family whose members are expressed primarily in the central and/or peripheral nervous system. This gene is thought to be involved in CNS development. Expansion of a polyalanine tract and other mutations in this gene cause X-linked cognitive disability and epilepsy. [provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
PM4
Nonframeshift variant in NON repetitive region in NM_139058.3.
BP6
Variant X-25013530-GGCCGCGGCGGCCGCGGCCGCGGCT-G is Benign according to our data. Variant chrX-25013530-GGCCGCGGCGGCCGCGGCCGCGGCT-G is described in ClinVar as [Likely_benign]. Clinvar id is 96454.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-25013530-GGCCGCGGCGGCCGCGGCCGCGGCT-G is described in Lovd as [Pathogenic].
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.000707 (74/104652) while in subpopulation AMR AF= 0.000879 (9/10236). AF 95% confidence interval is 0.000613. There are 0 homozygotes in gnomad4. There are 25 alleles in male gnomad4 subpopulation. Median coverage is 21. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd4 at 25 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARX | NM_139058.3 | c.441_464del | p.Ala148_Ala155del | inframe_deletion | 2/5 | ENST00000379044.5 | NP_620689.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARX | ENST00000379044.5 | c.441_464del | p.Ala148_Ala155del | inframe_deletion | 2/5 | 1 | NM_139058.3 | ENSP00000368332 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000707 AC: 74AN: 104666Hom.: 0 Cov.: 21 AF XY: 0.000836 AC XY: 25AN XY: 29914
GnomAD3 genomes
AF:
AC:
74
AN:
104666
Hom.:
Cov.:
21
AF XY:
AC XY:
25
AN XY:
29914
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000393 AC: 1AN: 2544Hom.: 0 AF XY: 0.00314 AC XY: 1AN XY: 318
GnomAD3 exomes
AF:
AC:
1
AN:
2544
Hom.:
AF XY:
AC XY:
1
AN XY:
318
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000508 AC: 360AN: 709130Hom.: 2 AF XY: 0.000461 AC XY: 99AN XY: 214590
GnomAD4 exome
AF:
AC:
360
AN:
709130
Hom.:
AF XY:
AC XY:
99
AN XY:
214590
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000707 AC: 74AN: 104652Hom.: 0 Cov.: 21 AF XY: 0.000836 AC XY: 25AN XY: 29920
GnomAD4 genome
AF:
AC:
74
AN:
104652
Hom.:
Cov.:
21
AF XY:
AC XY:
25
AN XY:
29920
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Uncertain:1Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Feb 08, 2013 | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Nov 04, 2013 | - - |
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jun 01, 2024 | ARX: BS2 - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 03, 2015 | - - |
Intellectual disability, X-linked, with or without seizures, arx-related Uncertain:1
Uncertain significance, no assertion criteria provided | literature only | OMIM | Jan 01, 2011 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 02, 2019 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Intellectual disability, X-linked, with or without seizures, arx-related;C3463992:Developmental and epileptic encephalopathy, 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at